Oligomeric/pS129 Alpha Synuclein LEAPS and Round Robin (2017)

The MJFox Foundation have assembled LEAPS team (linked-efforts to accelerate Parkinson’s solutions) to assess and cross-validate the various existing oligomeric and PS129 a-synuclein assays followed by initiation of a round robin where these assays will be used to assess pS129 and Oligomeric α-synuclein levels in well-characterized samples from PD and CT subjects.  


Hilal A. Lashuel, PhD, EPFL-Lausanne, Switzerland

Jing Zhang, MD, PhD, University of Washington, Seattle, Washington, United States

Omar El-Agnaf, PhD, Hamad Bin Khalifa University, Doha, Qatar,

Peggy Taylor, ScD, BioLegend, Inc., Massachusetts, United States

Brit Mollenhauer, MD, University Medical Center, Goettingen, Germany

Robert Umek, PhD, Meso Scale Discovery, Maryland, United States

Henrik Zetterberg, MD, PhD, University of Gothenburg, Mölndal, Sweden

Deniz Kirik, PhD, Lund University, Sweden

Andrea Caricasole, IRBM Promidis, Italy